EMILY MILLER: Open Payments
NPI 1689756942 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 33 payments from 12 companies in 2025. Trend: 2023 $488 · 2024 $662 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $184 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| PFIZER INC. | 5 | $92 |
| Amgen Inc. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 1 | $82 |
| ABBVIE INC. | 4 | $66 |
| AtriCure, Inc. | 1 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: Ozempic, REXULTI, FARXIGA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, OTEZLA, PREVNAR 20, UBRELVY, EVENITY.
Industry payments across SC — which companies pay providers there.
